[Form 4] Biodesix, Inc. Insider Trading Activity
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, had restricted stock units (RSUs) vest on 08/12/2025 that converted into 1,379 shares of common stock. The filing shows those 1,379 shares were recorded as acquired on 08/12/2025 and, to satisfy tax withholding, 442 shares were sold on 08/13/2025 at a weighted average price of $0.4163 per share (individual sale prices ranged from $0.4076 to $0.43). After these transactions, Mr. Pestano beneficially owned 157,878 shares of common stock. The RSUs vest quarterly in 16 installments beginning February 8, 2022, have no expiration date, and the sold shares were transacted automatically by the issuer's broker to cover taxes.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, ha visto maturare unità di azioni ristrette (RSU) il 12/08/2025 che si sono convertite in 1.379 azioni ordinarie. La comunicazione indica che quelle 1.379 azioni sono state annotate come acquisite il 12/08/2025 e, per soddisfare le ritenute fiscali, 442 azioni sono state vendute il 13/08/2025 a un prezzo medio ponderato di $0.4163 per azione (i prezzi individuali di vendita variavano da $0.4076 a $0.43). Dopo queste operazioni, il sig. Pestano deteneva beneficiariament 157.878 azioni ordinarie. Le RSU maturano trimestralmente in 16 tranche a partire dal 8 febbraio 2022, non hanno data di scadenza e le azioni vendute sono state liquidate automaticamente dal broker dell'emittente per coprire le imposte.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, tuvo unidades de acciones restringidas (RSU) que vencieron el 12/08/2025 y se convirtieron en 1.379 acciones comunes. El informe muestra que esas 1.379 acciones se registraron como adquiridas el 12/08/2025 y, para cubrir la retención fiscal, 442 acciones se vendieron el 13/08/2025 a un precio promedio ponderado de $0.4163 por acción (los precios individuales de venta oscilaron entre $0.4076 y $0.43). Tras estas transacciones, el Sr. Pestano poseía beneficiariamente 157.878 acciones comunes. Las RSU se consolidan trimestralmente en 16 pagos a partir del 8 de febrero de 2022, no tienen fecha de vencimiento y las acciones vendidas se ejecutaron automáticamente por el bróker del emisor para cubrir impuestos.
Biodesix, Inc. (BDSX) 보고� Gary Anthony Pestano, 최고개발책임�(CDO)� 2025-08-12� 제한주식단위(RSU)가 베스트되� 보통� 1,379주로 전환되었습니�. 제출 서류� 따르� 해당 1,379주는 2025-08-12� 취득으로 기록되었�, 세금 원천징수� 충당하기 위해 442주가 2025-08-13� 주당 가중평� 가� $0.4163� 매도되었습니�(개별 매도 가격은 $0.4076에서 $0.43 사이). � 거래� 이후 Pestano 씨는 보통� 157,878주를 실질적으� 보유하고 있었습니�. RSU� 2022� 2� 8일부� 분기별로 � 16회에 걸쳐 베스트되� 만기일이 없고, 매도� 주식은 발행사의 중개인이 세금 납부� 위해 자동으로 처리했습니다.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, a vu des unités d'actions restreintes (RSU) arriver à échéance le 12/08/2025, converties en 1 379 actions ordinaires. Le dépôt indique que ces 1 379 actions ont été enregistrées comme acquises le 12/08/2025 et que, pour couvrir la retenue fiscale, 442 actions ont été vendues le 13/08/2025 à un prix moyen pondéré de 0,4163 $ par action (les prix de vente individuels variaient de 0,4076 $ à 0,43 $). Après ces opérations, M. Pestano détenait utilement 157 878 actions ordinaires. Les RSU sont acquises trimestriellement en 16 versements à partir du 8 février 2022, n'ont pas de date d'expiration, et les actions vendues ont été cédées automatiquement par le courtier de l'émetteur pour couvrir les impôts.
Bei Biodesix, Inc. (BDSX) ist die meldepflichtige Person Gary Anthony Pestano, Chief Development Officer; ihm sind am 12.08.2025 Restricted Stock Units (RSUs) fällig geworden, die in 1.379 Stammaktien umgewandelt wurden. Die Meldung zeigt, dass diese 1.379 Aktien am 12.08.2025 als erworben verbucht wurden und zur Begleichung der Steuerabzüge 442 Aktien am 13.08.2025 zu einem gewichteten Durchschnittspreis von $0.4163 je Aktie verkauft wurden (einzelne Verkaufspreise reichten von $0.4076 bis $0.43). Nach diesen Transaktionen hielt Herr Pestano wirtschaftlich 157.878 Stammaktien. Die RSUs werden vierteljährlich in 16 Raten ab dem 8. Februar 2022 fällig, haben kein Ablaufdatum, und die verkauften Aktien wurden vom Broker des Emittenten automatisch zur Steuerdeckung veräußert.
- RSUs vested, converting compensation into equity which aligns the officer with shareholder interests
- Beneficial ownership remains substantial at 157,878 shares after the tax-withholding sale
- Automatic sale to cover taxes reduced the officer's holdings by 442 shares, representing a modest net decrease
Insights
TL;DR Routine RSU vesting and automatic tax-withholding sale; no sign of discretionary insider trading.
The filing documents standard equity compensation mechanics: vested RSUs converted into shares and a portion sold by the issuer's broker to cover tax obligations. The transaction was administratively driven (automatic sale) rather than an open-market disposition initiated by the officer. Post-transaction beneficial ownership remains materially intact at 157,878 shares. This is a routine governance event reflecting compensation delivery rather than a change in strategic ownership.
TL;DR Small net decrease in insider holdings due to tax-related sell; transaction sizes are immaterial to company capitalization.
The report shows 1,379 RSUs vested and 442 shares sold to cover taxes at a weighted average price of $0.4163. The scale of the sale is minor relative to typical public-company float and therefore unlikely to impact market perceptions or valuation materially. The continued schedule of quarterly vesting suggests ongoing compensation-related share issuance rather than near-term liquidity-driven selling by the officer.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, ha visto maturare unità di azioni ristrette (RSU) il 12/08/2025 che si sono convertite in 1.379 azioni ordinarie. La comunicazione indica che quelle 1.379 azioni sono state annotate come acquisite il 12/08/2025 e, per soddisfare le ritenute fiscali, 442 azioni sono state vendute il 13/08/2025 a un prezzo medio ponderato di $0.4163 per azione (i prezzi individuali di vendita variavano da $0.4076 a $0.43). Dopo queste operazioni, il sig. Pestano deteneva beneficiariament 157.878 azioni ordinarie. Le RSU maturano trimestralmente in 16 tranche a partire dal 8 febbraio 2022, non hanno data di scadenza e le azioni vendute sono state liquidate automaticamente dal broker dell'emittente per coprire le imposte.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, tuvo unidades de acciones restringidas (RSU) que vencieron el 12/08/2025 y se convirtieron en 1.379 acciones comunes. El informe muestra que esas 1.379 acciones se registraron como adquiridas el 12/08/2025 y, para cubrir la retención fiscal, 442 acciones se vendieron el 13/08/2025 a un precio promedio ponderado de $0.4163 por acción (los precios individuales de venta oscilaron entre $0.4076 y $0.43). Tras estas transacciones, el Sr. Pestano poseía beneficiariamente 157.878 acciones comunes. Las RSU se consolidan trimestralmente en 16 pagos a partir del 8 de febrero de 2022, no tienen fecha de vencimiento y las acciones vendidas se ejecutaron automáticamente por el bróker del emisor para cubrir impuestos.
Biodesix, Inc. (BDSX) 보고� Gary Anthony Pestano, 최고개발책임�(CDO)� 2025-08-12� 제한주식단위(RSU)가 베스트되� 보통� 1,379주로 전환되었습니�. 제출 서류� 따르� 해당 1,379주는 2025-08-12� 취득으로 기록되었�, 세금 원천징수� 충당하기 위해 442주가 2025-08-13� 주당 가중평� 가� $0.4163� 매도되었습니�(개별 매도 가격은 $0.4076에서 $0.43 사이). � 거래� 이후 Pestano 씨는 보통� 157,878주를 실질적으� 보유하고 있었습니�. RSU� 2022� 2� 8일부� 분기별로 � 16회에 걸쳐 베스트되� 만기일이 없고, 매도� 주식은 발행사의 중개인이 세금 납부� 위해 자동으로 처리했습니다.
Biodesix, Inc. (BDSX) reporting person Gary Anthony Pestano, Chief Development Officer, a vu des unités d'actions restreintes (RSU) arriver à échéance le 12/08/2025, converties en 1 379 actions ordinaires. Le dépôt indique que ces 1 379 actions ont été enregistrées comme acquises le 12/08/2025 et que, pour couvrir la retenue fiscale, 442 actions ont été vendues le 13/08/2025 à un prix moyen pondéré de 0,4163 $ par action (les prix de vente individuels variaient de 0,4076 $ à 0,43 $). Après ces opérations, M. Pestano détenait utilement 157 878 actions ordinaires. Les RSU sont acquises trimestriellement en 16 versements à partir du 8 février 2022, n'ont pas de date d'expiration, et les actions vendues ont été cédées automatiquement par le courtier de l'émetteur pour couvrir les impôts.
Bei Biodesix, Inc. (BDSX) ist die meldepflichtige Person Gary Anthony Pestano, Chief Development Officer; ihm sind am 12.08.2025 Restricted Stock Units (RSUs) fällig geworden, die in 1.379 Stammaktien umgewandelt wurden. Die Meldung zeigt, dass diese 1.379 Aktien am 12.08.2025 als erworben verbucht wurden und zur Begleichung der Steuerabzüge 442 Aktien am 13.08.2025 zu einem gewichteten Durchschnittspreis von $0.4163 je Aktie verkauft wurden (einzelne Verkaufspreise reichten von $0.4076 bis $0.43). Nach diesen Transaktionen hielt Herr Pestano wirtschaftlich 157.878 Stammaktien. Die RSUs werden vierteljährlich in 16 Raten ab dem 8. Februar 2022 fällig, haben kein Ablaufdatum, und die verkauften Aktien wurden vom Broker des Emittenten automatisch zur Steuerdeckung veräußert.